Chemoradiation in the management of cervix cancer: Current status and future directions

Oncology (Switzerland)

Volumn 84, Issue 4, 2013, Pages 246-250

  Markman, Maurie ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

Cervix cancer; Chemoradiation; Cisplatin; External beam radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GEMCITABINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; EVIDENCE BASED PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; UTERINE CERVIX CANCER;

EID: 84873368499     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000346804     Document Type: Review

References (32)

1. Cannistra SA, Niloff JM: Cancer of the uterine cervix. N Engl J Med 1996; 34: 1030-1038.
2. Moore DH: Chemotherapy for advanced, recurrent and metastatic cervical cancer. J Natl Compr Canc Netw 2008; 6: 53-57.
3. Tzioras S, Pavlidis N, Paraskevaidis E, et al: Effects of different chemotherapy regimens on survival for advanced cervical cancer: systemic review and meta-analysis. Cancer Treat Rev 2007; 33: 24-38.
4. Cadon I, van Gorp T, Amant F, et al: Chemotherapy for recurrent cervical cancer. Gynecol Oncol 2007; 107:S113-S118.
5. Hirte HW, Strychowsky JE, Oliver T, et al: Chemotherapy for recurrent, metastatic, or persistent cancer: a systemic review. Int J Gynecol Oncol 2007; 17: 1194-1204.
6. Bonomi P, Blessing JA, Stehman FB, et al: Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3: 1079-1085.
7. Movva S, Rodriguez L, Arias-Pulido H, et al: Novel chemotherapy approaches for cervical cancer. Cancer 2009; 115: 3166-3180.
8. Moore DH, Blessing JA, McQuellon RP, et al: Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2004; 22: 3113-3119.
9. Long HJ, Bundy BN, Grendys EC Jr, et al: Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 2005; 23: 4626-4632.
10. Monk BJ, Sill MW, McMeekin DS, et al: Phase III trial of four cisplatin-containing doublet combinations in stage IV, recurrent or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27: 4649-4655.
11. Moore DH, Tian C, Monk BJ, et al: Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2010; 116: 44-49.
12. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for highrisk cervical cancer. N Engl J Med 1999; 340: 1137-1143.
13. Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-1161.
14. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-1153.
15. Whitney CW, Sause W, Bundy BN, et al: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group Study. J Clin Oncol 1999; 17: 1139-1348.
16. Peters WA, Liu PY, Barrett RJ, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation alone as adjuvant therapy after radical surgery in highrisk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-1613.
17. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration: Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systemic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-5812.
18. Rose PG, Ali S, Watkins E, et al: Long-term follow-up of a randomized trial comparing concurrent cisplatin, cisplatin-based combination chemotherapy or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group study. J Clin Oncol 2007; 25: 2804-2810.
19. Eifel PJ, Winter K, Morris M, et al: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872-880.
20. National Cancer Institute: Clinical Announcement on Cervical Cancer. Bethesda, National Institutes of Health, 1999 http://rex. nci.nih.gov/massmedia/pressreleases/cervicalcancer. html
21. Pearcey R, Brundage M, Drouin P, et al: Phase III trial comparing radical radiotherapy with or without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-972.
22. Eifel PJ: Concurrent chemotherapy and radiation: a major advance for women with cervical cancer. J Clin Oncol 1999; 17: 1334-1335.
23. Duenas-Gonzalez A, Zarba JJ, Patel F, et al: Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2011; 29: 1678-1685.
24. Hernandez P, Olivera P, Duenas-Gonzalez A, et al: Gemcitabine activity in cervical cancer cell lines. Cancer Chemother Pharmacol 2001; 48: 488-492.
25. Thomas G: Are we making progress in curing advanced cervical cancer? J Clin Oncol 2011; 29: 1654-1656.
26. Rose PG, DeGeest K, McMeekin S, et al: A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2007; 107: 274-279.
27. Swisher EM, Swensen RE, Greer B, et al: Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase 1 trial of the Puget Sound Oncology Consortium. Gynecol Oncol 2006; 101: 429-435.
28. DiSilvestro P, Ali S, Peter C, et al: A Gynecologic Oncology Group phase III randomized trial of weekly cisplatin and radiation versus cisplatin and tirapazamine and radiation in stage IB2, IIA, IIIB and IVA cervical carcinoma limited to the pelvis. Gynecol Oncol 2012; 125:S3.
29. Monk BJ, Sill MW, Burger RA, et al: Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27: 1069-1074.
30. Schefter TE, Winter K, Kwon JS, et al: A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417. Int J Radiat Oncol Biol Phys 2012; 83: 1179-1184.
31. Monk BJ, Mas Lopez L, Zarba JJ, et al: Phase II open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced recurrent cervical cancer. J Clin Oncol 2010; 28: 3562-3569.
32. Moore KN, Sill MW, Miller DS, et al: A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2012; 127: 456-461.